Processing your payment...
Please do not close your browser.

Tissue Microarray Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Arrayit Corporation, BioVendor, BioChain Institute, 3DHISTECH

16 Aug, 2022 | 137 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

The global Tissue Microarray market size is expected to grow USD 21350.43 million by 2027, at a CAGR of 10.8% over the forecast period.



Tissue Microarray Market Overview



Tissue microarrays are paraffin blocks in which up to 1000 distinct cylindrical tissue cores can be joined in an array pattern, allowing the analysis of molecules present at the DNA, mRNA, and protein levels under similar controlled circumstances on a single glass slide. This adaptable approach, which uses automated data processing, enables both prospective and retrospective analyses of human tissue. The increase in the number of cancer patients, as well as the improvement of technology and the use of the microarray approach in proteomics and genomics due to its demand of fewer samples, uniformity in results, and rapid assay, is expected to drive tissue microarray market trends.



The key driver of the tissue microarray market's expansion is the rise of applications in drug discovery, the expansion of pharmaceutical businesses and biotechnology, the spread of cancer worldwide, and the rising demand for reliable and affordable diagnostic tools. With the aid of tissue microarray technology, thousands of genres have been identified that can be connected to progression, initiation, and development. Array-based technology provides platforms for profiling of tissues, including DNA array, tissue array, and disease genes. Additionally, the use of tissue microarrays in heterogeneous malignancies is not advantageous and is anticipated to hinder the market's expansion. Tissue microarray market expansion is expected to be fueled by the increasing use of microarray in a variety of applications, which would likely present a number of possibilities for leading industry participants.





Industry News and Updates



March 11, 2022: Boston Cell Standards launches consortium for IHC testing--

Boston Cell Standards recently launched the Consortium for Analytic Standardization in Immunohistochemistry (CASI), with the goal of improving patient immunohistochemistry (IHC) test accuracy and reproducibility. The consortium is led by an international panel of pathologists and scientists and is being funded by an initial $2 million grant from the U.S. National Cancer Institute.



What are the major Applications, Types and Regions for Tissue Microarray Market?



Market is segmented based on the type, applications, companies and regions.



By Type, it is segmented into




  • Immunohistochemistry

  • Fluorescent In-Situ Hybridization

  • Frozen Tissue Array

  • Others



By Application, it is segmented into




  • Oncology

  • Gene Expression Profiling

  • SNP Detection

  • Double-Stranded B-DNA Microarrays

  • Comparative Genomic Hybridization

  • Sequencing Bioinformatics



Tissue Microarray Market Regional Analysis



America is expected to dominate the tissue microarray market during the projected period due to an increase in cancer prevalence in the Americas, which is driving up demand for tissue microarrays in this region. Additionally, the growing use of tissue microarrays in drug discovery is beneficial for the market's expansion. A growing focus on the treatment of infectious diseases and cancer diagnostics is expected to cause Europe to represent the second-largest proportion of the global tissue microarray market. The growing population and changing lifestyles are projected to further increase the occurrence of cancer in this area, which will increase demand for tissue microarrays there.




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Tissue Microarray Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Tissue Microarray Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Tissue Microarray Market report scope?























































Report Attributes



Report Details



Forecast Period 2022 to 2027 CAGR



CAGR of 10.8% over the forecast period (2022-2027)



By Type




  • Immunohistochemistry

  • Fluorescent In-Situ Hybridization

  • Frozen Tissue Array

  • Others



By Application




  • Oncology

  • Gene Expression Profiling

  • SNP Detection

  • Double-Stranded B-DNA Microarrays

  • Comparative Genomic Hybridization

  • Sequencing Bioinformatics



By Companies



Arrayit Corporation, BioVendor, BioChain Institute, 3DHISTECH, Thermo Fisher Scientific, Diagnostic Technology, Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Phalanx Biotech, QIAGEN, Takara Bio, Perkin Elmer, Merck Sharp & Dohme Corp., Novus Biologicals, ProteoGenex, PREMIER Biosoft, OriGene, Biocompare, BioIVT, US Biolab, Protein Biotechnologies, BioCat GmbH, Bio SB, Creative Bioarray, Abcam, Auria Biobank



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



2022



Historical Year



2017 to 2021



Forecast Year



2022 to 2027



Number of Pages



137



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Frequently Asked Questions



What is the growth rate of Tissue Microarray Market?



The Tissue Microarray Market is growing at a CAGR of 10.8% over the next 5 years.



Who are the key players in Tissue Microarray Market?



Arrayit Corporation, BioVendor, BioChain Institute, 3DHISTECH, Thermo Fisher Scientific, Diagnostic Technology, Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Phalanx Biotech, QIAGEN, Takara Bio, Perkin Elmer, Merck Sharp & Dohme Corp., Novus Biologicals, ProteoGenex, PREMIER Biosoft, OriGene, Biocompare, BioIVT, US Biolab, Protein Biotechnologies, BioCat GmbH, Bio SB, Creative Bioarray, Abcam, Auria Biobank



What are the significant types of Tissue Microarray Market?



Fully Automated, Semi-Automated, Manual



What are the major end-use applications of Tissue Microarray Market?



Immunohistochemistry, Fluorescent In-Situ Hybridization, Frozen Tissue Array, Others



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.


  1. INTRODUCTION

    1. MARKET DEFINITION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMELINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL TISSUE MICROARRAY MARKET BY TYPE

    3. GLOBAL TISSUE MICROARRAY MARKET BY APPLICATION



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND FOR TISSUE MICROARRAY



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST ON MATERIALS



    3. OPPORTUNITIES

      1. TISSUE MICROARRAY GROWTH

      2. APPLICATION OF TISSUE MICROARRAY



    4. IMPACT OF COVID 19



  5. GLOBAL TISSUE MICROARRAY MARKET, BY TYPE

    1. INTRODUCTION

    2. IMMUNOHISTOCHEMISTRY

    3. FLUORESCENT IN-SITU HYBRIDIZATION

    4. FROZEN TISSUE ARRAY

    5. OTHERS



  6. GLOBAL TISSUE MICROARRAY MARKET, BY APPLICATION

    1. INTRODUCTION

    2. ONCOLOGY

    3. GENE EXPRESSION PROFILING

    4. SNP DETECTION

    5. DOUBLE-STRANDED B-DNA MICROARRAYS

    6. COMPARATIVE GENOMIC HYBRIDIZATION

    7. SEQUENCING BIOINFORMATICS



  7. GLOBAL TISSUE MICROARRAY MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. ARRAYIT CORPORATION

      2. BIOVENDOR

      3. BIOCHAIN INSTITUTE

      4. 3DHISTECH

      5. THERMO FISHER SCIENTIFIC

      6. DIAGNOSTIC TECHNOLOGY

      7. AGILENT TECHNOLOGIES

      8. ILLUMINA, INC.

      9. PROTEIN BIOTECHNOLOGIES INC.

      10. ASTERAND BIOSCIENCE

      11. PANTOMICS INC.

      12. APPLIED MICROARRAYS

      13. PHALANX BIOTECH

      14. QIAGEN

      15. TAKARA BIO

      16. PERKIN ELMER

      17. MERCK SHARP & DOHME CORP.

      18. NOVUS BIOLOGICALS

      19. PROTEOGENEX

      20. PREMIER BIOSOFT

      21. ORIGENE

      22. BIOCOMPARE

      23. BIOIVT

      24. US BIOLAB

      25. PROTEIN BIOTECHNOLOGIES

      26. BIOCAT GMBH

      27. BIO SB

      28. CREATIVE BIOARRAY

      29. ABCAM

      30. AURIA BIOBANK





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 3M
  • 3M
  • 9